Editorial: Real-world data and real-world evidence in lung cancer
- PMID: 38912056
- PMCID: PMC11190332
- DOI: 10.3389/fonc.2024.1436077
Editorial: Real-world data and real-world evidence in lung cancer
Keywords: lung cancer; prognosis; real-world data; real-world evidence; survival.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Real-world data and real-world evidence in lung cancer
References
-
- Omerovic E, Petrie M, Redfors B, Fremes S, Murphy G, Marquis-Gravel G, et al. . Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation. Trials. (2024) 25:80. doi: 10.1186/s13063-024-07935-y - DOI - PMC - PubMed
-
- Gristina V, Galvano A, Castellana L, Insalaco L, Cusenza S, Graceffa G, et al. . Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses. Ther Adv Med Oncol. (2021) 13:17588359211018018. doi: 10.1177/17588359211018018 - DOI - PMC - PubMed
-
- Gristina V, Barraco N, La Mantia M, Castellana L, Insalaco L, Bono M, et al. . Clinical potential of circulating cell-free DNA (cfDNA) for longitudinally monitoring clinical outcomes in the first-line setting of non-small-cell lung cancer (NSCLC): A real-world prospective study. Cancers (Basel). (2022) 14(23):6013. doi: 10.3390/cancers14236013 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources